Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer.

Maxime PatoutFlorian GuisierXavier BrunePierre BohnAnthony RomieuNasrin Sarafan-VasseurRichard SesboüéPierre-Yves RenardLuc ThibervilleMathieu Salaün

Published in: BMC pulmonary medicine (2019)

Real time molecular imaging using fluorescent erlotinib is able to identify ex vivo tumours with EGFR mutations.

Keyphrases